Evidence map›Paper›PMID 30656214›Full record

ArticleTransplantation direct2019

Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission.

Sarah L White, William Rawlinson, Peter Boan, Vicky Sheppeard, Germaine Wong, Karen Waller, Helen Opdam, John Kaldor, Michael Fink, Deborah Verran and 18 more

Abstract read
In one paragraph

Article in Transplantation direct, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Donor heart selection: Evidence-based guidelines for providers.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Guideline
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Effect of Carbapenem-ResistantInfection and drug resistance · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Sarah L WhiteCentral Clinical School, Sydney Medical School, The University of Sydney, Sydney, Australia.
William RawlinsonSerology and Virology Division, NSW Health Pathology Prince of Wales Hospital, Sydney, Australia.
Peter BoanDepartments of Infectious Diseases and Microbiology, Fiona Stanley Hospital, Perth, Australia.
Vicky SheppeardCommunicable Diseases Network Australia, New South Wales Health, Sydney, Australia.
Germaine WongCentre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia.
Karen WallerCentral Clinical School, Sydney Medical School, The University of Sydney, Sydney, Australia.
Helen OpdamAustin Health, Melbourne, Australia.
John KaldorKirby Institute, University of New South Wales, Sydney, Australia.
Michael FinkAustin Health, Melbourne, Australia.
Deborah VerranTransplantation Services, Royal Prince Alfred Hospital, Sydney, Australia.
Angela WebsterCentre for Transplant and Renal Research, Westmead Hospital, Sydney, Australia.
Kate WyburnCentral Clinical School, Sydney Medical School, The University of Sydney, Sydney, Australia.
Lindsay GraysonAustin Health, Melbourne, Australia.
Allan GlanvilleDepartment of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital, Sydney, Australia.
Nick CrossDepartment of Nephrology, Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand.
Ashley IrishDepartment of Nephrology, Fiona Stanley Hospital, Perth, Australia.
Toby CoatesRenal and Transplantation, Royal Adelaide Hospital, Adelaide, Australia.
Anthony GriffinRenal Transplantation, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Greg SnellLung Transplant, Alfred Health, Melbourne, Victoria, Australia.
Stephen I AlexanderCentre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
Scott CampbellDepartment of Renal Medicine, University of Queensland at Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Steven ChadbanCentral Clinical School, Sydney Medical School, The University of Sydney, Sydney, Australia.
Peter MacdonaldDepartment of Cardiology, St Vincent's Hospital, Sydney, Australia.
Paul ManleyKidney Disorders, Auckland District Health Board, Auckland City Hospital, Auckland, New Zealand.
Eva MehakovicThe Organ and Tissue Authority, Australian Government, Canberra, Australia.
Vidya RamachandranSerology and Virology Division, NSW Health Pathology Prince of Wales Hospital, Sydney, Australia.
Alicia MitchellDepartment of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital, Sydney, Australia.
Michael IsonDivisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2016, the Transplantation Society of Australia and New Zealand, with the support of the Australian Government Organ and Tissue authority, commissioned a literature review on the topic of infectious disease transmission from deceased donors to recipients of solid organ transplants. The purpose of this review was to synthesize evidence on transmission risks, diagnostic test characteristics, and recipient management to inform best-practice clinical guidelines. The final review, presented as a special supplement in Transplantation Direct, collates case reports of transmission events and other peer-reviewed literature, and summarizes current (as of June 2017) international guidelines on donor screening and recipient management. Of particular interest at the time of writing was how to maximize utilization of donors at increased risk for transmission of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus, given the recent developments, including the availability of direct-acting antivirals for hepatitis C virus and improvements in donor screening technologies. The review also covers emerging risks associated with recent epidemics (eg, Zika virus) and the risk of transmission of nonendemic pathogens related to donor travel history or country of origin. Lastly, the implications for recipient consent of expanded utilization of donors at increased risk of blood-borne viral disease transmission are considered.

Identifiers

PMID30656214
PMCPMC6324914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.